GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+5.59%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$144M
AUM Growth
+$144M
(+30%)
Cap. Flow
+$30.3M
Cap. Flow
% of AUM
21.1%
Top 10 Holdings %
Top 10 Hldgs %
31.75%
Holding
94
New
35
Increased
11
Reduced
9
Closed
23
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$5.22M |
| 2 |
Zimmer Biomet
ZBH
|
$5.03M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$4.49M |
| 4 |
AGN
ALLERGAN INC
AGN
|
$4.46M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$4.06M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$6.17M |
| 2 |
Cooper Companies
COO
|
$5.42M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$5.24M |
| 4 |
Boston Scientific
BSX
|
$5.11M |
| 5 |
Insmed
INSM
|
$4M |
Sector Composition
| 1 | Healthcare | 80.91% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPNC
26
DELISTED
Spectranetics Corp
SPNC
| $2.66M | 1.44% |
100,000
-42,600
| -30% | -$1.13M |
|
27
Bruker
BRKR
$4.45B
| $2.59M | 1.41% |
140,000
+10,000
| +8% | +$185K |
|
28
Edwards Lifesciences
EW
$47.7B
| $2.55M | 1.39% |
25,000
+5,000
| +25% | +$511K |
|
29
Exact Sciences
EXAS
$9.33B
| $2.42M | 1.32% |
+125,000
| New | +$2.42M |
|
|
CMRX
30
DELISTED
Chimerix, Inc.
CMRX
| $2.22M | 1.21% |
+80,500
| New | +$2.22M |
|
31
PTC Therapeutics
PTCT
$4.41B
| $2.2M | 1.19% |
+50,000
| New | +$2.2M |
|
|
ATRS
32
DELISTED
Antares Pharma, Inc.
ATRS
| $2.01M | 1.09% |
+1,100,000
| New | +$2.01M |
|
|
AEGR
33
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $2M | 1.09% |
+60,000
| New | +$2M |
|
34
Medtronic
MDT
$118B
| $1.86M | 1.01% |
30,000
-45,000
| -60% | -$2.79M |
|
35
Assertio
ASRT
$78M
| $1.82M | 0.99% |
120,000
| – | – |
|
36
Tandem Diabetes Care
TNDM
$834M
| $1.77M | 0.96% |
+131,500
| New | +$1.77M |
|
|
NUVA
37
DELISTED
NuVasive, Inc.
NUVA
| $1.74M | 0.95% |
+50,000
| New | +$1.74M |
|
38
Adverum Biotechnologies
ADVM
$68.2M
| $1.71M | 0.93% |
+50,000
| New | +$1.71M |
|
39
Neurocrine Biosciences
NBIX
$13.5B
| $1.57M | 0.85% |
+100,000
| New | +$1.57M |
|
40
Larimar Therapeutics
LRMR
$337M
| $1.47M | 0.8% |
+75,000
| New | +$1.47M |
|
41
Enanta Pharmaceuticals
ENTA
$189M
| $1.39M | 0.75% |
35,000
-15,000
| -30% | -$594K |
|
|
CASC
42
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $1.34M | 0.73% |
+700,000
| New | +$1.34M |
|
43
Smith & Nephew
SNN
$16.2B
| $1.26M | 0.69% |
15,000
-5,000
| -25% | -$421K |
|
|
BLUE
44
DELISTED
bluebird bio
BLUE
| $1.26M | 0.68% |
+35,000
| New | +$1.26M |
|
45
Agios Pharmaceuticals
AGIO
$2.36B
| $1.23M | 0.67% |
+20,000
| New | +$1.23M |
|
46
Puma Biotechnology
PBYI
$258M
| $1.19M | 0.65% |
5,000
+4,000
| +400% | +$954K |
|
|
NSTG
47
DELISTED
NanoString Technologies, Inc.
NSTG
| $985K | 0.53% |
90,000
+20,000
| +29% | +$219K |
|
|
RCPT
48
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $764K | 0.41% |
12,300
-22,700
| -65% | -$1.41M |
|
|
BIOL
49
DELISTED
Biolase, Inc.
BIOL
| $747K | 0.41% |
300,000
| – | – |
|
|
OCRX
50
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $613K | 0.33% |
125,000
+25,000
| +25% | +$123K |
|